Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic - leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.
The CovidSurg Collaborative has projected that, based on a 12-week period of peak disruption to hospital services due to COVID-19, 28.4 million elective surgeries worldwide will cancelled or postponed in 2020.
The modelling study, published in the British Journal of Surgery, indicates that each additional week of disruption to hospital services will be associated with a further 2.4 million cancellations.
Led by researchers at the University of Birmingham, researchers collected detailed information from surgeons across 359 hospitals and 71 countries on plans for cancellation of elective surgery. This data was then statistically modelled to estimate totals for cancelled surgery across 190 countries (attached).
The researchers project that worldwide 72.3% of planned surgeries would be cancelled through the peak period of COVID-19 related disruption. Most cancelled surgeries will be for non-cancer conditions. Orthopaedic procedures will be cancelled most frequently, with 6.3 million orthopaedic surgeries cancelled worldwide over a 12-week period. It is also projected that globally 2.3 million cancer surgeries will be cancelled or postponed.
In the United Kingdom, the National Health Service advised hospitals to cancel most elective surgeries for 12 weeks. It is estimated that this will result in 516,000 cancelled surgeries, including 36,000 cancer procedures. These cancellations will create a backlog that will need to be cleared after the COVID-19 disruption ends.
If, after the disruption ends, the NHS increases the number of surgeries performed each week by 20% compared to pre-pandemic activity, it will take 11 months to clear the backlog. However, each additional week of disruption will lead to the cancellation of an extra 43,300 surgeries, significantly extending the period it will take to clear the backlog.
Mr. Aneel Bhangu, Consultant Surgeon and Senior Lecturer at the NIHR Global Health Research Unit on Global Surgery at the University of Birmingham commented: "During the COVID-19 pandemics elective surgeries have been cancelled to reduce the risk of patients being exposed to COVID-19 in hospital, and to support the wider hospital response, for example by converting operating theatres in to intensive care units.
"Although essential, cancellations place a heavy burden on patients and society. Patients' conditions may deteriorate, worsening their quality of life as they wait for rescheduled surgery. In some cases, for example cancer, delayed surgeries may lead to a number of unnecessary deaths."
Dr. Dmitri Nepogodiev, Research Fellow at the NIHR Global Health Research Unit on Global Surgery at the University of Birmingham said: "Each additional week of disruption to hospital services results in an additional 43,300 surgeries being cancelled, so it is important that hospitals regularly assess the situation so that elective surgery can be resumed at the earliest opportunity.
"Clearing the backlog of elective surgeries created by COVID-19 will cost the National Health Service at least £2 billion. The Government must ensure that the NHS is provided with additional funding and resources to ramp up elective surgery to clear the backlog."
###A spreadsheet is available on request providing country-level data for 190 countries including the proportions of operations cancelled (by surgery type) and total numbers of operations projected to be cancelled during peak 12 weeks of COVID-19 disruption (by surgery type).
For more information, interviews and to request a copy of the country-data spreadsheet, please contact Tony Moran, International Communications Manager, University of Birmingham on +44 (0) 121 414 8254 or +44 (0)782 783 2312 or email@example.com. For out-of-hours enquiries, please call +44 (0) 7789 921 165.
Notes to Editors
Country-level data on cancelled elective surgery is available in the study manuscript for 190 countries. This data is split in to 15 specialties providing a comprehensive overview of the local impact of COVID-19 on surgery.
The CovidSurg Collaborative is a research network focussed on the impact of COVID-19 on surgical care. Over 5,000 surgeons from across 120 countries are participating in the CovidSurg programme. The Collaborative is leading two cohort studies collecting patient-level surgical outcomes data; currently data on 7,500 patients have been entered by 440 hospitals worldwide.
This study was led by CovidSurg Collaborative members based in the United Kingdom, Benin, Ghana, India, Italy, Mexico, Nigeria, Rwanda, Spain, South Africa, and the United States.
The University of Birmingham is ranked amongst the world's top 100 institutions, its work brings people from across the world to Birmingham, including researchers and teachers and more than 6,500 international students from over 150 countries.
The National Institute for Health Research (NIHR) awarded £7 million to the University of Birmingham to establish the NIHR Global Health Research Unit on Global Surgery. This unit is engaged in conducting multi-country randomised controlled trials testing interventions to reduce SSI across a range of low- and middle-income countries. It has established sustainable partnerships with the aim of leveraging global policy change:
Benin - University of Abomey-Calavi, Cotonou
Ghana - University of Development Studies, Tamale
India - CMC Ludhiana, Punjab
Mexico - Hospital Espanol, Veracruz
Nigeria - Lagos University Teaching Hospital, Lagos & Obafemi Awolowo University Teaching Hospitals, Ile-Ife
Rwanda - University of Rwanda; University Teaching Hospital, Kigali
South Africa - Chris Hani Baragwanath Academic Hospital, Johannesburg
The NIHR is the UK's largest funder of health and care research. The NIHR:
Funds, supports and delivers high quality research that benefits the NHS, public health and social care
Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research
Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future
Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services
Partners with other public funders, charities and industry to maximise the value of research to patients and the economy The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR commissions applied health research to
benefit the poorest people in low and middle-income countries, using Official Development Assistance funding.